Lipocine (LPCN) Misses Q2 EPS by 41c

Lipocine (NASDAQ: LPCN) reported Q2 EPS of ($0.41). Revenue for the quarter came in at $620 thousand.

For earnings history and earnings-related data on Lipocine (LPCN) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• UBS Upgrades Intermedia Capital Group (ICG:LN) (ICGUF) to Buy
• Increasing unusual put option volume: OSS CTSH PZZA BFLY CDNS WMB KD DFTX CAN HIVE SOC WYFI SIMO